Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+53.6%/yr
vs +25.3%/yr prior
Acceleration
+28.3pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
3.6x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.52M | +97.9% |
| 2024 | $11.38M | +69.0% |
| 2023 | $6.73M | +8.4% |
| 2022 | $6.21M | - |
| 2021 | $0.00 | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $2.52M | +254.2% |
| 2017 | $710375.00 | -3.3% |
| 2016 | $734288.00 | - |